https://stock.noler.com/us/stock/bionik-laboratories-corp https://stock.noler.com/us/stock/bionik-laboratories-corp/accounts-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/bionik-laboratories-corp/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/accounts-receivable https://stock.noler.com/us/stock/bionik-laboratories-corp/accretion-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/accretion-of-discount https://stock.noler.com/us/stock/bionik-laboratories-corp/accrued-liabilities-current https://stock.noler.com/us/stock/bionik-laboratories-corp/accrued-liabilities-for-commissions-expense-and-taxes https://stock.noler.com/us/stock/bionik-laboratories-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/bionik-laboratories-corp/accumulated-depreciation https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-cash-and-equivalents https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-current-assets-receivables https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-current-liabilities-accounts-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-current-liabilities-long-term-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-current-liabilities-other https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-equipment https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-inventory https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-net https://stock.noler.com/us/stock/bionik-laboratories-corp/acquired-noncurrent-liabilities-long-term-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-consideration-transferred https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-pro-forma-information-earnings-or-loss-of-acquiree-since-acquisition-date-actual https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-pro-forma-information-revenue-of-acquiree-since-acquisition-date-actual https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/bionik-laboratories-corp/acquisitions https://stock.noler.com/us/stock/bionik-laboratories-corp/additional-paid-in-capital https://stock.noler.com/us/stock/bionik-laboratories-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/bionik-laboratories-corp/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/allowance-for-loan-and-lease-losses-write-offs https://stock.noler.com/us/stock/bionik-laboratories-corp/amortization https://stock.noler.com/us/stock/bionik-laboratories-corp/aoci https://stock.noler.com/us/stock/bionik-laboratories-corp/basic-shares https://stock.noler.com/us/stock/bionik-laboratories-corp/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/bionik-laboratories-corp/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/business-acquisitions-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/bionik-laboratories-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/bionik-laboratories-corp/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/bionik-laboratories-corp/capital-expenditures https://stock.noler.com/us/stock/bionik-laboratories-corp/capital-lease-obligations-current https://stock.noler.com/us/stock/bionik-laboratories-corp/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/bionik-laboratories-corp/cash https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-acquired-from-acquisition https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-and-equivalents https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-change https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-fdic-insured-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/cash-flow-breakdown https://stock.noler.com/us/stock/bionik-laboratories-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/bionik-laboratories-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/bionik-laboratories-corp/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bionik-laboratories-corp/common-stock-value https://stock.noler.com/us/stock/bionik-laboratories-corp/common-stock-value-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/comprehensive-income https://stock.noler.com/us/stock/bionik-laboratories-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/bionik-laboratories-corp/contract-liability https://stock.noler.com/us/stock/bionik-laboratories-corp/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/bionik-laboratories-corp/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/bionik-laboratories-corp/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/convertible-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/convertible-debt-current https://stock.noler.com/us/stock/bionik-laboratories-corp/convertible-long-term-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/convertible-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/convertible-notes-payable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/cost-of-revenue https://stock.noler.com/us/stock/bionik-laboratories-corp/cost-of-revenue-2 https://stock.noler.com/us/stock/bionik-laboratories-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/current-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/current-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/customer-deposits-current https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-face-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-revenue https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-net-current https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities-deferred-expense-deferred-financing-costs https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities-other https://stock.noler.com/us/stock/bionik-laboratories-corp/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/bionik-laboratories-corp/depreciation https://stock.noler.com/us/stock/bionik-laboratories-corp/depreciation-and-amortization https://stock.noler.com/us/stock/bionik-laboratories-corp/depreciation-and-amortization-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/bionik-laboratories-corp/derivative-gain-on-derivative https://stock.noler.com/us/stock/bionik-laboratories-corp/derivative-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/bionik-laboratories-corp/diluted-shares https://stock.noler.com/us/stock/bionik-laboratories-corp/due-from-related-parties https://stock.noler.com/us/stock/bionik-laboratories-corp/due-from-related-parties-current https://stock.noler.com/us/stock/bionik-laboratories-corp/due-to-officers-or-stockholders-current-and-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/due-to-related-parties-current https://stock.noler.com/us/stock/bionik-laboratories-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/bionik-laboratories-corp/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/bionik-laboratories-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/bionik-laboratories-corp/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/eps https://stock.noler.com/us/stock/bionik-laboratories-corp/eps-basic https://stock.noler.com/us/stock/bionik-laboratories-corp/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/bionik-laboratories-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/bionik-laboratories-corp/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/finance-lease-principal-payments https://stock.noler.com/us/stock/bionik-laboratories-corp/financing-cash-flow https://stock.noler.com/us/stock/bionik-laboratories-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/bionik-laboratories-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/bionik-laboratories-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/foreign-pretax-income https://stock.noler.com/us/stock/bionik-laboratories-corp/form-d-other https://stock.noler.com/us/stock/bionik-laboratories-corp/form-d-stocks https://stock.noler.com/us/stock/bionik-laboratories-corp/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/bionik-laboratories-corp/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/gains-losses-on-restructuring-of-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/general-and-administrative-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-acquired https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-change https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-gross https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-impairment-loss https://stock.noler.com/us/stock/bionik-laboratories-corp/goodwill-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/bionik-laboratories-corp/grants-receivable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/gross-profit https://stock.noler.com/us/stock/bionik-laboratories-corp/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/bionik-laboratories-corp/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/bionik-laboratories-corp/income-loss-from https://stock.noler.com/us/stock/bionik-laboratories-corp/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/bionik-laboratories-corp/income-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/income-taxes-paid https://stock.noler.com/us/stock/bionik-laboratories-corp/income-taxes-paid-2 https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accounts-receivable-and-other-operating-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/bionik-laboratories-corp/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/bionik-laboratories-corp/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/indefinite-lived-intangible-assets-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/bionik-laboratories-corp/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-corporate-securities https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-other https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-other/sales https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/bionik-laboratories-corp/insider-transactions-warrants https://stock.noler.com/us/stock/bionik-laboratories-corp/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-and-debt-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-costs-capitalized https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-expense-on-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-expense-related-party https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-income-expense-net https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-income-related-party https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-paid https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-paid-net https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-payable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/interest-receivable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/inventory https://stock.noler.com/us/stock/bionik-laboratories-corp/inventory-finished-goods https://stock.noler.com/us/stock/bionik-laboratories-corp/inventory-raw-materials https://stock.noler.com/us/stock/bionik-laboratories-corp/inventory-work-in-process https://stock.noler.com/us/stock/bionik-laboratories-corp/inventory-write-down https://stock.noler.com/us/stock/bionik-laboratories-corp/investing-cash-flow https://stock.noler.com/us/stock/bionik-laboratories-corp/investment-income-interest https://stock.noler.com/us/stock/bionik-laboratories-corp/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/bionik-laboratories-corp/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/bionik-laboratories-corp/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/bionik-laboratories-corp/loans-and-leases-receivable-related-parties https://stock.noler.com/us/stock/bionik-laboratories-corp/loans-payable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/loans-receivable-net https://stock.noler.com/us/stock/bionik-laboratories-corp/long-term-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/long-term-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/management-fee-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/bionik-laboratories-corp/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/bionik-laboratories-corp/net-cash-from https://stock.noler.com/us/stock/bionik-laboratories-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/net-change-in-cash https://stock.noler.com/us/stock/bionik-laboratories-corp/net-income https://stock.noler.com/us/stock/bionik-laboratories-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/bionik-laboratories-corp/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/bionik-laboratories-corp/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/bionik-laboratories-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/bionik-laboratories-corp/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/bionik-laboratories-corp/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/bionik-laboratories-corp/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/bionik-laboratories-corp/notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/notes-payable-current https://stock.noler.com/us/stock/bionik-laboratories-corp/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/number-of-operating-segments https://stock.noler.com/us/stock/bionik-laboratories-corp/number-of-reporting-units https://stock.noler.com/us/stock/bionik-laboratories-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/oci-net-of-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-cash-flow https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-expenses https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-income https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-cost https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-liability https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-liability-current https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/bionik-laboratories-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/bionik-laboratories-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/bionik-laboratories-corp/other-commitment-due-in-next-twelve-months https://stock.noler.com/us/stock/bionik-laboratories-corp/other-expenses https://stock.noler.com/us/stock/bionik-laboratories-corp/other-income https://stock.noler.com/us/stock/bionik-laboratories-corp/other-income-2 https://stock.noler.com/us/stock/bionik-laboratories-corp/other-noncash-income-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/other-noncurrent-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/other-nonoperating-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/other-nonoperating-income https://stock.noler.com/us/stock/bionik-laboratories-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/other-operating-income https://stock.noler.com/us/stock/bionik-laboratories-corp/other-operating-income-expense-net https://stock.noler.com/us/stock/bionik-laboratories-corp/other-prepaid-expense-current https://stock.noler.com/us/stock/bionik-laboratories-corp/other-receivables-net-current https://stock.noler.com/us/stock/bionik-laboratories-corp/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/bionik-laboratories-corp/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/bionik-laboratories-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/bionik-laboratories-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/payments-for-proceeds-from-loans-receivable https://stock.noler.com/us/stock/bionik-laboratories-corp/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/bionik-laboratories-corp/payments-to-acquire-other-receivables https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-shares-facts https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-value https://stock.noler.com/us/stock/bionik-laboratories-corp/preferred-stock-value-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/bionik-laboratories-corp/prepaid-expense-current https://stock.noler.com/us/stock/bionik-laboratories-corp/prepaid-insurance https://stock.noler.com/us/stock/bionik-laboratories-corp/prepaid-taxes https://stock.noler.com/us/stock/bionik-laboratories-corp/pretax-income https://stock.noler.com/us/stock/bionik-laboratories-corp/pretax-income-domestic https://stock.noler.com/us/stock/bionik-laboratories-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-short-term-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/bionik-laboratories-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/bionik-laboratories-corp/product-warranty-accrual https://stock.noler.com/us/stock/bionik-laboratories-corp/product-warranty-accrual-preexisting-increase-decrease https://stock.noler.com/us/stock/bionik-laboratories-corp/product-warranty-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/professional-fees https://stock.noler.com/us/stock/bionik-laboratories-corp/profit-loss https://stock.noler.com/us/stock/bionik-laboratories-corp/property-plant-and-equipment-additions https://stock.noler.com/us/stock/bionik-laboratories-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/bionik-laboratories-corp/property-plant-equipment https://stock.noler.com/us/stock/bionik-laboratories-corp/provision-for-doubtful-accounts https://stock.noler.com/us/stock/bionik-laboratories-corp/public-float https://stock.noler.com/us/stock/bionik-laboratories-corp/purchase-obligation https://stock.noler.com/us/stock/bionik-laboratories-corp/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/bionik-laboratories-corp/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/bionik-laboratories-corp/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/bionik-laboratories-corp/related-party-transaction-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/related-party-transaction-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/bionik-laboratories-corp/repayments-of-convertible-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/bionik-laboratories-corp/repayments-of-other-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/repayments-of-related-party-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/repayments-of-short-term-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/research-and-development https://stock.noler.com/us/stock/bionik-laboratories-corp/retained-earnings https://stock.noler.com/us/stock/bionik-laboratories-corp/revenue https://stock.noler.com/us/stock/bionik-laboratories-corp/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/bionik-laboratories-corp/revenue-from-related-parties https://stock.noler.com/us/stock/bionik-laboratories-corp/sales-revenue-net https://stock.noler.com/us/stock/bionik-laboratories-corp/secured-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/secured-demand-notes https://stock.noler.com/us/stock/bionik-laboratories-corp/selling-and-marketing-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/bionik-laboratories-corp/share-price https://stock.noler.com/us/stock/bionik-laboratories-corp/shareholders-equity https://stock.noler.com/us/stock/bionik-laboratories-corp/shares-authorized https://stock.noler.com/us/stock/bionik-laboratories-corp/shares-issued https://stock.noler.com/us/stock/bionik-laboratories-corp/shares-issued-shares-new-issues https://stock.noler.com/us/stock/bionik-laboratories-corp/short-term-borrowings https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-non-option-equity-instruments-expirations https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-based-compensation https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-option-plan-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-exercisable-number https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-expirations-in-period https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/bionik-laboratories-corp/stock-split-ratio https://stock.noler.com/us/stock/bionik-laboratories-corp/subordinated-debt https://stock.noler.com/us/stock/bionik-laboratories-corp/supplies https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-credit-carryforward-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/bionik-laboratories-corp/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/bionik-laboratories-corp/total-assets https://stock.noler.com/us/stock/bionik-laboratories-corp/total-liabilities https://stock.noler.com/us/stock/bionik-laboratories-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/bionik-laboratories-corp/utb-resulting-in-net-operating-loss-carryforward https://stock.noler.com/us/stock/bionik-laboratories-corp/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/bionik-laboratories-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/bionik-laboratories-corp/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/bionik-laboratories-corp/variable-lease-cost https://stock.noler.com/us/stock/bionik-laboratories-corp/warrants-and-rights-outstanding https://stock.noler.com/us/stock/bionik-laboratories-corp/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/bionik-laboratories-corp/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/bionik-laboratories-corp/write-off-of-inventory